Sartorius Stedim Biotech Stock
Stocks
DIM
FR0013154002
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
Market Closed -
Euronext Paris
19:55:00 04/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 190.30 EUR | -4.18% |
|
-3.74% | -9.38% |
| 08-20 | UBS Upgrades Sartorius Stedim Biotech to Buy, Boosts PT | MT |
| 08-20 | European stock markets slip as oil prices surge again |  |
| Market Cap | 18.52B 21.52B 17.42B 15.91B 29.77B 2,032B 29.85B 206B 79.88B 1,042B 80.8B 79.04B 3,358B | P/E 2026 * |
48.5x | P/E 2027 * | 37.7x |
|---|---|---|---|---|---|
| Enterprise Value | 20.52B 23.85B 19.31B 17.64B 33B 2,252B 33.09B 228B 88.54B 1,155B 89.56B 87.61B 3,722B | EV / Sales 2026 * |
6.56x | EV / Sales 2027 * | 5.84x |
| Free-Float |
28.47% | Yield 2026 * |
0.44% | Yield 2027 * | 0.53% |
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| DIM | Real-time | |
CBOE
| DIMp | Real-time | |
|
Börse Stuttgart
| 56S1 | Delayed | |
|
Tradegate
| 56S1 | Real-time | |
|
OTC Markets
| SDMHF | Delayed | |
|
CBOE
| 0NK7 | Real-time | |
|
Xetra
| 56S1 | Delayed | |
|
Boerse Muenchen
| 56S1 | Real-time | |
|
Deutsche Boerse AG
| 56S1 | Delayed | |
|
London S.E.
| 0NK7 | Delayed | |
|
Borsa Italiana
| 4DIM | End-of-day quote | |
|
Wiener Boerse
| DIM | End-of-day quote |
Last Transcript : Sartorius Stedim Biotech
| 1 day | -4.18% | ||
| 1 week | -3.74% | ||
| Current month | -2.91% | ||
| 1 month | +10.06% | ||
| 3 months | +3.59% | ||
| 6 months | +8.90% | ||
| Current year | -9.38% |
| 1 week | 190.3 |  | 203 |
| 1 month | 173.8 | | 203 |
| Current year | 150 | | 224 |
| 1 year | 150 | | 224 |
| 3 years | 139.1 | | 281 |
| 5 years | 139.1 | | 551 |
| 10 years | 50.13 | | 551 |
| Manager | Title | Age | Since |
|---|---|---|---|
René Fáber
CEO | Chief Executive Officer | 51 | 28/03/2023 |
| Chief Tech/Sci/R&D Officer | 61 | 08/09/2011 | |
Petra Müller
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 65 | 07/04/2015 | |
Susan Dexter
BRD | Director/Board Member | 69 | 07/04/2015 |
Lothar Kappich
BRD | Director/Board Member | 69 | 14/09/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 17/12/25 | Sell | Company | 750,000 | 0.7706% | ||
| 16/02/24 | Buy | Chief Executive Officer | 1,716,739 | 1.8624% | ||
| 02/03/22 | Sell | Company | 200,442 | 0.2174% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.18% | -3.74% | +11.32% | -27.62% | 22.46B | |
| -0.42% | -3.68% | -18.43% | +5.33% | 188B | |
| +1.15% | +3.22% | +1.42% | +14.66% | 119B | |
| -1.86% | +2.77% | +13.07% | +89.16% | 64.35B | |
| -1.31% | -1.09% | +22.44% | +46.84% | 52.59B | |
| -1.54% | -2.52% | -3.41% | -33.66% | 51.11B | |
| -2.02% | -3.22% | +8.84% | -13.73% | 33.85B | |
| 0.00% | +3.71% | - | - | 32.1B | |
| -0.81% | +0.74% | +37.34% | -16.61% | 24.12B | |
| -1.44% | -4.21% | -7.37% | +11.97% | 23.39B | |
| Average | -1.24% | +0.20% | +7.25% | +8.48% | 61.14B | |
| Weighted average by Cap. | -0.69% | +0.16% | -0.30% | +13.85% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.13B 3.63B 2.94B 2.69B 5.03B 343B 5.04B 34.76B 13.49B 176B 13.65B 13.35B 567B | 3.47B 4.03B 3.26B 2.98B 5.58B 381B 5.59B 38.56B 14.96B 195B 15.14B 14.81B 629B |
| Net income | 381M 443M 359M 328M 613M 41.85B 615M 4.24B 1.65B 21.47B 1.66B 1.63B 69.17B | 483M 561M 455M 415M 777M 53.01B 779M 5.37B 2.08B 27.2B 2.11B 2.06B 87.62B |
| Net Debt | 2.01B 2.33B 1.89B 1.73B 3.23B 220B 3.24B 22.33B 8.66B 113B 8.76B 8.57B 364B | 1.76B 2.04B 1.65B 1.51B 2.82B 193B 2.83B 19.52B 7.57B 98.82B 7.66B 7.49B 318B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/09/26 | €190.30 | -4.18% | 63,469 |
| 03/09/26 | €198.60 | +0.35% | 79,897 |
| 02/09/26 | €197.90 | +1.33% | 93,408 |
| 01/09/26 | €195.30 | -0.36% | 120,335 |
| 31/08/26 | €196.00 | -0.86% | 219,124 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- DIM Stock
Select your edition
All financial news and data tailored to specific country editions
